COLTENE Holding AG (SWX:CLTN)
Switzerland
· Delayed Price · Currency is CHF 48.30
-2.60 (-5.11%)
Mar 9, 2026, 5:31 PM CET
COLTENE Holding AG Revenue
In the year 2025, COLTENE Holding AG had annual revenue of 240.57M CHF, down -3.83%. COLTENE Holding AG had revenue of 118.05M in the half year ending June 30, 2025, a decrease of -10.18%.
Revenue
240.57M
Revenue Growth
-3.83%
P/S Ratio
1.26
Revenue / Employee
204.56K
Employees
1,176
Market Cap
304.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 240.57M | -9.59M | -3.83% |
| Dec 31, 2024 | 250.16M | 7.43M | 3.06% |
| Dec 31, 2023 | 242.73M | -24.40M | -9.13% |
| Dec 31, 2022 | 267.13M | -12.12M | -4.34% |
| Dec 31, 2021 | 279.24M | 30.89M | 12.44% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Galderma Group AG | 4.16B |
| Lonza Group AG | 6.53B |
| Newron Pharmaceuticals | 55.93M |
| IVF Hartmann Holding AG | 159.69M |
| DocMorris AG | 1.06B |
| Santhera Pharmaceuticals Holding AG | 49.02M |